Markets desk

Morning report — Tue 29 Sep 2026 ~07:48 HKT (research/paper)

Research/paper only. No live orders or recommendations. KRX Tue cash — open 29 Sep 09:00 KST (Mon was first session after Chuseok).

watchlists US AJ: no new overnight board rows (Outlook HYROX path only this fire; Featured not re-scraped). X color: NVDA +$150bn buyback (AJ); Anthropic $518bn 2027 infra; Samsung Foundry 2nm yield ~60%. Standing Y: AVGO, MU, MRVL, NVDA (HC), XPEV, META, AMD, LITE. Wait ORCL; Caution TSLA, NIO; Watch SPCX; Avoid EOSE, EOS; N PLTR, AAPL, RIVN. Korea attractive: EMPTY (Mon foreign dump leaves no new long sleeve). 000660 is Hynix desk only.

asia news Age-cut Mon+Tue n=8. Lead: MiniMax M3.1-Flash public test; DeepSeek DSec agent-sandbox paper; SCMP ByteDance ~1/5 China DC + CanSemi IPO 2,360×; Herald/Yonhap KOSPI −2.70% foreign ₩3tn Samsung/Hynix dump; Yonhap Huang Van Fleet; SCMP HK export AI lift; BOK Sep CBSI 99.1. HKET 403; KED sections empty.

X Morning refresh 2026-09-29 07:48 HKT · Sentiment mixed, medium · Home unavailable · n_new=3 after 22:00 HKT. NEW: Jukan Samsung 2nm yield ~60%; Zephyr Anthropic $518bn 2027 cloud/infra; AJ NVDA +$150bn buyback. PRIOR (eve demoted): SEMCO ₩4.27tn FC-BGA; Anthropic >$180bn contracted; VIS Singapore; META Enterprise; AJ Xpeng FSD; SKHY Japan fab / MLCC.

DART Age-window ≥Mon 28 15:40 KST: 6 keeps (no 000660) — Cellbion 308430 up 3-8%/p≈40% MFDS Phase-3 Lu-177; Gabia 079940 mixed 1-3%/p≈28% Align inspector; MOA Life Plus 142760 mixed 8%+/p≈42% ₩4.0bn 3rd-party; Dongwha 025900 mixed 1-3%; TKG Huchems 069260 up 1-3%; Digi.I 043360 mixed 8%+. last_seen 20260929000017 @09:24 KST

funding BN fapi GEO-BLOCKED. HL xyz:SKHY mark 183.31 / fund 6.25e-06; xyz:SKHX mark 1302.5 / fund 6.25e-06. BN−HL spreads UNKNOWN. Paper only.

Hynix KR PREOPEN → 09:00. Mon cash 000660 ₩1,768,000 (−5.05%) O/H/L 1,825k/1,840k/1,768k · vol 3,302,748 · For −988.5k sh / Inst −274.9k / Ind +676.1k; FO 49.94% (Herald ₩1.73tn foreign sell). Tue PREOPEN over ₩1,769,000 (+0.06%). Samsung Mon ₩270,000 (−5.43%) / over ₩267,500 (−0.93%). KOSPI Mon 6,889.74 (−2.70%). SKHY Mon $181.92 (−5.03%); prem vs Mon KRX/FX 1,358 ≈ +39.73%. No NEW 000660 DART. Do not treat Yahoo as a Tue gap invent.

HYROX Warsaw registration announced (not open): opens 14 Oct 2026 12:00 CET / 18:00 HKT; race 7–11 Apr 2027. Official “Sale starts soon”. Outlook: no newer Warsaw OPEN mail. ping_needed=false.

MFDS Phase-3 plan APPROVAL for Lu-177 DGUL (Pocuvotide) in mCRPC — 150 pts; applied 30 Jun, approved 28 Sep

2026-09-29 07:38 KST: Cellbion (셀비온, 308430, KOSDAQ) filed an ad-hoc fair disclosure — investment-judgment major matter (clinical-trial plan approval etc.). Title: multicenter, open-label, randomized Phase-3 clinical-trial plan APPROVAL evaluating efficacy and safety of Lutetium(177Lu) DGUL (Pocuvotide tetraxetan) in patients with metastatic castration-resistant prostate cancer (mCRPC). Stage: Phase 3. Approving authority: MFDS (식품의약품안전처). Country: Korea. Sites: multicenter (Seoul National University Hospital etc.). Indication: mCRPC. Application date: 2026-06-30. Approval/decision date: 2026-09-28. Registration No.: 20260131137. Primary objective: rPFS of BSC/SoC + Lu-177 DGUL vs BSC/SoC alone (BICR, PCWG3 modified RECIST v1.1). Design: 150 subjects 1:1 randomized; Lu-177 DGUL q6w ×4 (up to +2 = max 6); cross-over allowed after radiographic progression in control arm. Trial period: ~36 months from IRB approval; expected end 2030-01-31. Fact date / confirmation: 2026-09-28 (= MFDS approval notice date). Risk notes on form: ~10% historical drug-approval odds; commercial plans may change. Related prior: 2026-06-30 Phase-3 plan APPLICATION filing. rcpNo 20260929900003 / dcmNo 11593074 confirmed on DART HTML viewer (셀비온 matches). Live at enrich (Naver 308430 @2026-09-29 ~08:10 KST, PREOPEN): last/prev-close ₩14,790 (Mon 28 close); shares 12,905,251; mcap ≈ ₩1,909억 (₩190.9bn).

What: Overnight Cellbion disclosed MFDS approval of its Korea Phase-3 plan for Lu-177 DGUL (Pocuvotide) in mCRPC — 150-patient multicenter open randomized add-on vs BSC/SoC, applied 30 Jun and approved 28 Sep, with ~36-month run to a 2030-01-31 expected end. Why up: Phase-3 CTA/plan approval is real pipeline progression for a radiopharma name whose lead asset just cleared the regulatory gate to start pivotal dosing — not an affiliate restatement and not a soft IR guide. Why 3-8%: This is plan approval to start Phase 3, not a CSR/efficacy win (Inventera class is hotter); Jun-30 application already telegraphed the calendar, and the form itself cites ~10% historical approval odds — refuse 8%+ binary-shock. Refuse 1-3%: on a ~₩191bn KOSDAQ biotech into a clean pre-open window the tape can still clear mid-band. Why p≈40%: Stamp 07:38 KST into the 09:00 auction is unused leftover (pre-open rule); haircut for telegraphed Jun application and for biotech gap two-way risk.

DART

Align Partners court petition to appoint EGM inspector for 8 Oct meeting — control-fight process stamp

2026-09-29 07:32 KST: Gabia (가비아, 079940, KOSDAQ) filed litigation etc. raised/applied (경영권 분쟁 소송). Case name: appointment of inspector (검사인 선임). Case No.: 2026비합10052. Court: Suwon District Court Anyang Branch (수원지방법원 안양지원). Applicant/plaintiff: Align Partners Asset Management Co., Ltd. (얼라인파트너스자산운용주식회사) + 1 other. Respondent: Gabia, Inc. Relief sought: court-appointed inspector to investigate legality of convening procedures and resolution methods for the extraordinary general meeting scheduled 2026-10-08 11:00 (incl. adjourned/continued/changed meetings), covering board convening resolution, notice content, shareholder access, proxy review, voting (incl. confirmation of voting-rights restrictions under Suwon Anyang 2026카합10156), ballot handling, and minutes — inspector fees to be borne by Gabia. Company response: will respond under legal procedures. Application/confirmation dates: 2026-09-28. Related prior: 2026-09-23 EGM convening notice; 2026-08-28 record-date / EGM convening resolution. rcpNo 20260929900001 / dcmNo 11593053 confirmed on DART HTML viewer (가비아 matches). Live at enrich (Naver 079940 @2026-09-29 ~08:10 KST, PREOPEN): last/prev-close ₩40,350 (Mon 28 close); shares 13,420,684; mcap ≈ ₩5,415억 (₩541.5bn).

What: Overnight Gabia disclosed that Align Partners (+1) petitioned the Anyang court (2026비합10052) to appoint an inspector over the 8 Oct EGM’s convening/voting legality — sequel to the Aug-28 EGM resolution and Sep-23 convening notice, and tied to an existing voting-rights restriction case (2026카합10156). Why mixed: A control-fight process stamp that can still whip governance premium or short-covering, but petition ≠ inspector granted ≠ board flip (Mobile Appliance / Gabia-DCK class) — not a clean directional event. Why 1-3%: On a ~₩542bn KOSDAQ name this is incremental process inside a known fight, not a new tender or SPA; refuse mid-single inventing a significant move. Why p≈28%: Pre-open leftover into 09:00 is unused; haircut because the Oct-8 EGM path was already telegraphed since late August.

DART

₩4.0bn third-party placement 4.0m sh @ ₩1,000 (~40% mcap / +19% shares) — Med Investment becomes new largest shareholder

2026-09-29 07:30 KST: MOA Life Plus (모아라이프플러스, 142760, KOSDAQ) filed a material report — decision on paid-in capital increase (유상증자결정). New common shares: 4,000,000; par ₩1,000. Pre-deal issued common: 21,083,490. Method: third-party allotment (제3자배정증자). Purpose: operating funds ₩4,000,000,000 (=₩4.0bn / 40억). Issue price: ₩1,000/sh. Reference price: ₩478 (min of 1m/1w/latest WASP simple avg vs latest WASP). Premium vs reference: form lists 할증율 209.2% (issue = 209.2% of ₩478 reference; Commercial Act Art. 330 par floor when discounted calc < par). Allottee: Med Investment Partnership (메드투자조합) 4,000,000 sh — relationship "-"; GP/100% LP Choi Jae-in (최재인); partnership property ₩10,000,000; funding via capital + borrowings. Pay-in: 2026-10-14. Dividend start: 2026-01-01. Listing scheduled: 2026-11-04. Board: 2026-09-28 (outside directors blank; auditor absent). Securities registration statement: exempt (1-year mandatory holding on all new shares). Notes: on pay-in completion the largest shareholder will change to Med Investment Partnership; schedule may slip with regulators. Use of proceeds: operating funds ₩2.0bn in 2026 + ₩2.0bn in 2027. rcpNo 20260928000396 / dcmNo 11593008 confirmed on DART HTML viewer (주식회사 모아라이프플러스 matches). Live at enrich (Naver 142760 @2026-09-29 ~08:10 KST, PREOPEN): last/prev-close ₩471 (Mon 28 close); shares 21,083,490; mcap ≈ ₩99.3억 (₩9.93bn); raise/mcap ≈ 40.3%; new shares/OS ≈ 19.0%; issue ₩1,000 = +112% vs last ₩471.

What: Overnight MOA Life Plus board-approved a ₩4.0bn third-party placement of 4.0m common @ ₩1,000 (par floor; ~19% of 21.08m shares / ~40% of the ~₩9.9bn mcap) to Med Investment Partnership, with pay-in 14 Oct / list 4 Nov, 1-year lockup, and explicit largest-shareholder flip to Med on pay-in. Why mixed: Control-bid cash at a large premium to the ₩471 last is real (Artist Studio / Nexa / K3I class), but +19% share count + opaque ₩10m-property partnership buyer + listing overhang is the other leg — not a clean UP. Why 8%+: Face is ~40% of a ₩10bn microcap with a stated control change — overnight gap/volatility class, not a 1-3% grind. "8%+" here is volatility band, not one-way drift. Why p≈42%: Pre-open 07:30→09:00 leftover is unused; haircut for thin-name two-way whip and for a possible prior Sep-16 2m-share raise path already in the narrative.

DART

₩150bn funding-support guarantee for M-Park SPC (17% equity / ~43% mcap) — affiliate liquidity path TBD

2026-09-28 16:00 KST: Dongwha Enterprise (동화기업, 025900, KOSDAQ) filed a decision on debt guarantee for others (타인에대한채무보증결정). Debtor: Park DB First Co., Ltd. (파크디비제일차 주식회사) — relationship: none (SPC set up for this loan ABL/securitization). Creditor: DB Securities Co., Ltd. (디비증권). Debt (borrowed) amount: ₩150,000,000,000 (=₩150.0bn / 1,500억). Guarantee amount: ₩150,000,000,000 (=₩150.0bn) — funding-support (자금보충) obligation; on default, conditional assumption of SPC loan principal/interest to lenders. Equity on the form (2025 YE consolidated): ₩880,173,716,773 (=₩880.17bn) → guarantee/equity 17.04%. Large-corporation filer: yes. Guarantee period: 2026-09-30 → 2028-09-30 (may move with amortization). Total guarantee balance: ₩612,386,171,400 (=₩612.39bn). Board / decision date: 2026-09-28 (1 outside director present; auditor present). Notes: loan funds Park-DB-First so it can on-lend to affiliate M-Park (엠파크); M-Park proceeds are intended as Dongwha parent liquidity, but method/size not yet decided; FX for foreign guarantees uses Hana first mid on 2026-09-28; debtor is new SPC so summary financials blank. rcpNo 20260928900439 / dcmNo 11592343 confirmed on DART HTML viewer (동화기업 matches). Live at enrich (Naver 025900 @2026-09-28 ~16:06 KST, after cash close): close ₩6,870 (+140 / +2.08% vs prev ₩6,730); open ₩6,850; high ₩7,040 (+4.61%); low ₩6,650; vol 110,315; mcap ≈ ₩3,473억 (₩347.3bn); guarantee/mcap ≈ 43.2%. After-hours over ≈ ₩6,900 (+2.53%).

What: After the cash close Dongwha Enterprise approved a ₩150bn (=17% of YE2025 equity / ~43% of ~₩347bn mcap) funding-support guarantee so SPC Park DB First can finance affiliate M-Park, with proceeds notionally earmarked for Dongwha parent liquidity (structure/size still unset), lifting total guarantees to ₩612bn. Why mixed: Credit/guarantee stamps are stronger than backlog, and a path to parent liquidity is real — but this is contingent funding-support plus conditional debt assumption on a related-party loop, not new booked cash. Why 1-3%: Face/mcap is large (EcoPlastic/Namkwang class), yet contingent ≠ same-session cash hole; cut the band vs a clean equity raise. Why p≈25%: After-close so overnight is the product; tape only +2.1%/high +4.6% leaves most of a 1-3% band unused, haircut for shrug-risk on affiliate guarantee optics.

DART

₩337.8bn nitric-acid offtake to Indonesia BKP (30% sales / ~47% mcap) — supply 2029–2039; zero advance; secrecy-held until today

2026-09-28 15:51 KST: TKG Huchems (티케이지휴켐스, 069260, KOSPI) filed a single sales·supply contract (단일판매ㆍ공급계약체결). Type: other sales·supply / nitric acid supply contract (질산 공급계약 체결). Contract amount: ₩337,824,000,000 (=₩337.8bn / 3,378.2억). Recent sales (YE2025 consolidated): ₩1,127,691,137,096 (=₩1,127.69bn) → 30.0% of sales. Large-corporation filer: no. Counterparty: blank on form ("-"); relation "-". Supply region: Indonesia. Contract period: 2029-03-31 → 2039-03-30. Advance/down payment: none (무). Payment: against shipping docs under L/C. Contract/award date: 2026-09-23. Disclosure reserved for business secrecy until 2029-03-31. Notes: face = 10y planned volume (180kt/year) × Aug-2026 feedstock prices at Hana first mid ₩1,360.0/USD on 2026-09-23; period anchors to commercial ops start of PT. BATUTA KIMIA PERDANA (BKP) ammonium-nitrate plant in Kalimantan (expected supply start 2029-03-31); volume/price may change with counterparty offtake, feedstock and FX. rcpNo 20260928800375 / dcmNo 11592318 confirmed on DART HTML viewer (티케이지휴켐스 matches). Live at enrich (Naver 069260 @2026-09-28 ~16:06 KST, after cash close): close ₩17,740 (+1,540 / +9.51% vs prev ₩16,200); open ₩16,170; high ₩19,310 (+19.20%); low ₩16,120; vol 294,926; mcap ≈ ₩7,203억 (₩720.3bn); face/mcap ≈ 46.9%. After-hours over ≈ ₩17,760 (+9.63%).

What: After the cash close TKG Huchems disclosed a ₩337.8bn (=30% of YE2025 sales / ~47% of ~₩720bn mcap) nitric-acid offtake for BKP’s Kalimantan ammonium-nitrate plant, sized off 180kt/y × Aug-2026 feedstock, running 31 Mar 2029 → 30 Mar 2039, with zero advance and L/C payment — board dated 23 Sep and held under secrecy until today. Why up: Named multi-year chemical offtake into a new regional AN train is real volume visibility the tape can capitalize, not an affiliate restatement. Why 1-3%: Face clears every size bar, but first cash is ~2.5y out with no down payment — HMM/long-duration class, not an 8%+ near-term fuel print (sales % ≠ price band). Why p≈20%: After-close so overnight→09:00 is the product, but same-day cash already +9.5%/high +19.2% before the stamp (leak-or-unrelated) cuts unused leftover hard.

DART

₩16.5bn 100% buy of Green Pack (cosmetics PE-tube maker) — ~78% of mcap / ~41% equity; deposit today, ₩12.5bn cash by 28 Oct, ₩4bn earnout

2026-09-28 15:42 KST: Digi.I (디지아이, 043360, KOSDAQ) filed a material report — decision to acquire shares/equity of another corporation (타법인주식및출자증권양수결정). Target: Green Pack Co., Ltd. (그린팩); nationality Korea; CEO Cheon Hyo-man (천효만); capital ₩700,000,000; issued shares 70,000; main business: cosmetics plastic/tube molding equipment manufacture. Relation on form: largest shareholder (of target). No 3rd-party new-share buy in prior 6 months. Acquire: 70,000 shares (100%) for ₩16,500,000,000 (=₩16.5bn / 165억). Digi.I total assets (YE2025 K-IFRS): ₩43,764,106,692 → face/assets 37.70%. Digi.I equity: ₩40,303,244,481 → face/equity 40.94%. Post-deal ownership: 70,000 shares / 100.00%. Purpose: enter cosmetics PE-tube manufacturing via control. Share-transfer scheduled date: 2026-09-28. Sellers: Cheon Hyo-man 60,300 sh / ₩14,936,250,000; Lee Myeong-ju (이명주) 9,500 / ₩1,530,000,000; Cheon A-reum (천아름) 200 / ₩33,750,000. Payment (cash): (1) deposit ₩1,250,000,000 on 2026-09-28; (2) balance ₩11,250,000,000 on 2026-10-28; (3) deferred ₩4,000,000,000 to Cheon Hyo-man only, payable 2027–2031 the day after a clean audit confirms year sales/EBITDA hurdles (2027: sales ≥₩23.0bn & EBITDA ≥₩3.0bn; then 25/3, 27/3, 28/3, 30/3) — shortfalls reduce the earnout. Funding: own cash and bank borrowings. External fairness opinion: Hanmi Accounting (2026-08-24→09-23); DCF equity value ₩14,203m–₩18,706m; deal ₩16,500m inside range — not found unfair. Board 2026-09-28 (0 outside directors; auditor attended). FTC filing: yes. No put option. No reverse-merger plan. Target summary financials (₩m): H1-2026 assets 16,511 / equity 2,639 / sales 9,548 / NI 857 (accounting diligence); prior year sales 14,994 / NI 801 with qualified audit (한정) by Taeil. rcpNo 20260928000226 / dcmNo 11592297 confirmed on DART HTML viewer (디지아이 matches). Live at enrich (Naver 043360 @2026-09-28 ~15:48 KST, cash closed): ₩2,340 (−10 / −0.43% vs prev ₩2,350); open ₩2,350; high ₩2,350; low ₩2,245; vol 15,095; mcap ≈ ₩211억 (₩21.1bn); face/mcap ≈ 78.2%; Digi YE2025 sales ≈ ₩213억 (₩21.3bn) → face/sales ≈ 77%.

What: After the cash close Digi.I (043360) board-approved buying 100% of Green Pack (cosmetics PE-tube maker) for ₩16.5bn (= ~78% of ~₩21.1bn mcap / ~41% of YE2025 equity / ~77% of Digi YE2025 sales), with ₩1.25bn deposit today, ₩11.25bn on 28 Oct, and ₩4bn contingent 2027–2031 earnout; share transfer dated 28 Sep; funded by cash+bank debt; Hanmi DCF ₩14.2–18.7bn brackets the price. Why mixed: Real control + new vertical at a fairness-bracketed price, but transformative cash/debt outlay vs a still-lossy Digi balance sheet, target prior qualified audit, and multi-year earnout — not a clean bullish order print. Why 8%+: Face ≫ mcap on a ₩21bn / 15k-ADV name is overnight shock class, not mid-single-digit. Why p≈40%: After-close with tape unused (−0.43%) so next open is the window; haircut for funding/earnout/Silla ignore-risk on debt-funded microcap M&A.

DART

MiniMax launches M3.1-Flash-Preview text/coding model into public testing

Mon 28 Sep: MiniMax began public testing of M3.1-Flash-Preview — native multimodal, ~1M-token context, aimed at bug-fix through full feature work; some developers linked it to the anonymous “Space Bunny” model that topped OpenRouter/OpenCode usage over Mid-Autumn.

Why it matters: Hard rank-a China AI ship print inside Tue age-cut — keeps MiniMax in the ship-often race vs DeepSeek/Kimi/Zhipu/Qwen; supportive HK/China AI beta, not a same-session 000660 earnings catalyst.

source

DeepSeek publishes DSec agent-training sandbox paper (Liang Wenfeng on author list)

Mon 28 Sep: DeepSeek + Tsinghua released DeepSeek Elastic Compute (DSec) tech report — production sandbox infra behind V3.2→V4.1 agent training; ~3M sandboxes/day, peak concurrency >380k, create >5k/s; Liang ranked last among 130+ authors.

Why it matters: Hard rank-a DeepSeek infra/agent-stack signal — constructive China frontier-lab tape; reinforces AI-compute demand narrative that still coexists with Mon KR chip risk-off.

source

ByteDance grabs about one-fifth of China’s data-centre capacity as AI drives infra boom

Mon 28 Sep SCMP: ByteDance estimated to control ~20% of mainland data-centre capacity amid AI training/inference buildout — largest single-tenant color in China DC scramble.

Why it matters: Hard rank-a China AI infra demand — supportive HSI AI/data-centre beta and NVDA-China adjacency; pairs with Mon KR selloff narrative on AI-capex timing risk (two-way).

source

Chinese chip foundry CanSemi’s IPO oversubscribed 2,360× as investors chase AI boom

Mon 28 Sep SCMP: CanSemi (China domestic foundry) IPO books oversubscribed ~2,360 times — retail/institutional chase of AI-linked semiconductor capacity names on the mainland listing calendar.

Why it matters: Soft-hard China chip/AI listing froth — supportive China semi beta; contrast with Mon KRX foreign dump of Samsung/Hynix (risk appetite split Asia vs KR large-cap memory).

source

KOSPI −2.70% to 6,889.74 as foreigners dump ~₩3tn Samsung + SK hynix

Mon 28 Sep first cash after Chuseok: KOSPI 6,889.74 (−191.18 / −2.70%); KOSDAQ 846.58 (+0.25%). Samsung ₩270,000 (−5.43%); SK hynix ₩1,768,000 (−5.05%). Foreigners net sold ₩3.24tn on KOSPI incl. ₩1.73tn Hynix + ₩1.38tn Samsung. Drivers cited: US long yields (10y >5.2% / 30y >5.5%), AI data-centre delay concerns, Solidigm IPO dilution talk.

Why it matters: Hard session print for 000660/005930/KOSPI into Tue open — foreign flow + rates/AI-capex narrative set the overnight leftover; Tue PREOPEN Hynix flat-ish (+0.06% over) vs Samsung soft (−0.93% over).

source

Nvidia CEO Huang receives Van Fleet Award; Samsung Lee and SK Chey attend

Tue 29 Sep Yonhap (event Mon NY): Jensen Huang awarded Korea Society Van Fleet Award for Korea–US AI/semi partnership; Samsung Chairman Lee Jae-yong and SK Group Chairman Chey Tae-won attended the gala.

Why it matters: Soft NVDA–Korea diplomatic/industrial color — supportive narrative adjacency for 000660/005930/NVDA, not a same-session cash catalyst into Tue auction.

source

Strong AI demand prompts Hong Kong trade body to raise export growth forecast

Mon 28 Sep SCMP: HK trade body lifts export growth outlook citing strong AI-related demand — rare upward revision color for HK goods trade into AI cycle.

Why it matters: Soft constructive HSI/HK trade-AI beta — pairs with Mon HSI +0.54% while KRX chip large-caps sold off.

source

BOK: September business sentiment slips from nearly four-year high on rising costs

Tue 29 Sep: BOK Composite Business Sentiment Index 99.1 in Sep (−0.5pt m/m) after Aug 102 peak since Sep 2022; manufacturers 99.5 (from 103.8); non-manufacturing improved. Reading <100 = pessimists > optimists.

Why it matters: Soft Korea macro color into Tue cash — mild headwind vs chip-beta, not a direct Hynix filing; contrasts Sun KCCI Q4 BSI improvement story (outside age-cut).

source

Best paper arb idea (Tue open): Mon foreign dump left cash −5% with Tue over only +0.06% while ADR prem still ~+40% and overnight Anthropic $518bn / NVDA buyback tape bid. Watch 09:00 auction reclaim vs fade, HL xyz:SKHY↔Mon ADR tightness, and whether foreign selling persists. Micron 30 Sep calendar. Research/paper only. Field: /workspace/desk-site/_pack/20260929-am/.

Live marks refreshed 2026-09-29 07:48 HKT / 2026-09-29 08:48 KST. BN fapi GEO-BLOCKED — BN−HL mark bp UNKNOWN. ADR/KRX cross-session prem ~+39.73%. Research/paper only.

HL xyz dex OK: xyz:SKHY mark 183.31 / fund 6.25e-06. xyz:SKHX mark 1302.5 / fund 6.25e-06. Rates move; paper only.

BN: fapi SKHYUSDT/SKHYNIXUSDT restricted-location (451). No BN marks this fire.

Paper only. No fills. No live bots. Caveat: without BN, spread/arb watch is HL↔ADR only.

Ticker	Follow	Note
AVGO	Y	Live. Standing Y. Unchanged.
NIO	Y caution	China concentration. Unchanged.
EOS	Y avoid	Still avoid.
NVDA	Y	Live / HC. AJ +$150bn buyback confirm + Anthropic $518bn 2027 infra — constructive US-hours color; Huang Van Fleet Korea award soft.
MRVL	Y	Unchanged.
MU	Y	Micron earnings 30 Sep is the week’s memory calendar — more salient after Mon KR memory dump.
XPEV	Y	Standing Y. PRIOR Xpeng FSD pace vs Tesla.
META	booked	Enterprise Platform PRIOR = color only.
AMD	Y	TSMC 2nm / foundry color intact.
LITE	Y	Standing Y. Paper until memo body checked.
ORCL	Y	Wait sleeve. Unchanged (DC-delay narrative was part of Mon KR sell color).
PLTR / AAPL	N / event	Unchanged.
EOSE	avoid	AJ red flags
TSLA	caution	Xpeng FSD pace PRIOR + EU share ATL — caution stack intact; Samsung 2nm→Tesla supply note is foundry color not a TSLA Y.
SPCX	watch	Watch, not a Y.
RIVN	N	Skip.
DELL	watch title	Not a Y.
INTC	color	Still not an AJ Y (jukan 2nm note mentions Intel 18A as peer, not a buy).

2026-09-29 07:48 HKT / 2026-09-29 08:48 KST. No brand-new Y ticker. Paper.

PREOPEN → OPEN 09:00 KST — Tue 29 Sep 2026. Attractive list EMPTY besides Hynix desk (Mon foreign ₩3.24tn KOSPI sell / chip −5% leaves no fresh long sleeve). Mon cash: KOSPI 6,889.74 (−2.70%); 000660 ₩1,768,000 (−5.05%); 005930 ₩270,000 (−5.43%). Tue over 000660 ₩1,769,000 (+0.06%) / 005930 ₩267,500 (−0.93%). Won 1,358. SKHY Mon $181.92; prem ≈ +39.73%. HSI Mon 24,642.51 (+0.54%). No 000660 DART keep. data.krx missing.

DART live pack (≥Mon 28 15:40 KST): 6 keeps — Cellbion / Gabia / MOA Life Plus (overnight) + Dongwha / TKG Huchems / Digi.I (Mon after-close). Into Tue auction leftover mainly on overnight three.

Samsung Foundry 2nm (SF2) yield reportedly ~60% (from mid-50s); focus shifting to performance-per-watt / SF2P; Tesla 2nm supply framed as springboard for more big-tech wins. TSMC still ~72.5% foundry share vs Samsung ~5.9%.

Implication: Constructive 005930 Foundry narrative into Tue KR — yield/maturity color vs Mon cash −5.43%; not a volume/earnings print but soft support for foundry optionality (pairs with prior QCOM–Samsung 2nm).

x.com/jukan05/status/2104714825289158762

ANTHROPIC TO SPEND $518B ON CLOUD, INFRASTRUCTURE IN 2027.

Implication: Very large constructive AI-capex / cloud demand signal into Asia morning — extends evening Anthropic contracted-value >$180bn print; supportive NVDA/TSM/000660 complex, against Mon KR “AI DC delay” sell narrative.

x.com/zephyr_z9/status/2104713641186750840

AJ: Nvidia increased share buyback by $150bn — now by far the largest buyback in the market; claim that a prior “unlock largest buyback” call came true; NVDA +30% since that subscriber note.

Implication: Constructive NVDA capital-return / confidence signal on Y-list NVDA — US-hours confirmation color; not KR cash alpha into 09:00.

x.com/alojoh/status/2104624877462282426

Samsung Electro-Mechanics (009150) to invest ₩4.27tn (~$4.4bn / 43.6% equity) in FC-BGA package-substrate capacity through May 2028; Vietnam sub factory expansion ₩2.51tn.

Implication: Constructive SEMCO/advanced packaging tape — pairs with afternoon MLCC tightness; KR components capacity build still the evening lead.

x.com/jukan05/status/2104496290692526548

NVIDIA: Anthropic’s reported contracted value exceeds $180bn.

Implication: Large constructive NVDA AI-demand/backlog signal into US hours — reinforces foundry/HBM pull (TSM/000660 complex) alongside afternoon SKHY Japan fab.

x.com/zephyr_z9/status/2104537102168007002

$TSM affiliate VIS inaugurated Singapore advanced chip plant (sold out); power/analog/auto-industrial; also supports TSMC interposers; second fab eyed.

Implication: Soft constructive TSM ecosystem / specialty-foundry capacity (legacy+interposer) — not HBM core but supports AI packaging chain.

x.com/zephyr_z9/status/2104514369128427789

Meta launching Meta Enterprise Platform as next major AI business pillar (superintelligence framing).

Implication: META AI monetization narrative — constructive optionality on Y-list META; execution/spend vs margin still open.

x.com/zephyr_z9/status/2104550609403695581

AJ: Xpeng FSD already looks better than Tesla FSD v12.5; Xpeng could reach today’s Tesla FSD level in <2 years if pace holds.

Implication: Adds to TSLA caution stack (with EU share ATL PRIOR) — FSD competitive gap vs China OEM narrative.

x.com/alojoh/status/2104536615318331472

PRIOR (aft): Korean media — SK Hynix begun foundation work for Japan fab ($SKHY).

Implication: 000660/SKHY capacity narrative still intact into Tue KR open.

x.com/jukan05/status/2104404535267696859

PRIOR (aft): MLCC supply situation worsening.

Implication: Pairs with evening SEMCO FC-BGA capex — components tightness/build theme.

x.com/jukan05/status/2104395506562765010

PRIOR (AM): TSMC 2nm bookings up 10–20%; wafer capacity pull-forward to ~120k/mo by YE26.

Implication: Still lead constructive TSM/AI foundry signal; pairs with evening VIS Singapore fab.

x.com/jukan05/status/2104347149148528903

Xinhua Amsterdam road test: XPENG and Tesla intellig driving both smooth on canals/trams/bikes ($XPEV).

Implication: Mixed EV ADAS tape — XPEV visibility; not a clean TSLA negative on its own (pairs with FSD pace post above).

x.com/alojoh/status/2104453097095373130

PRIOR (aft): banks/stablecoins; QNT +158% on Clearing House Quant pick.

Implication: Fintech/stablecoin-infra — not KR memory core.

x.com/citrini/status/2104403330743279907

Method: morning GraphQL UserTweets (cookie auth, qid qJy3MbaNndtzxf9IqUzxMg); HomeLatest unresolved. Cutoff for NEW: after 2026-09-28 22:00 HKT. Priority: @alojoh @citrini @zephyr_z9 @jukan05 @BowTiedBull. priority_scrape.cutoff now 2026-09-29 07:48 HKT.